SAMSRITA LABS LIMITED

BSE: SAMSRITA539267ISIN INE579N01018

Healthcare
Healthcare Service Provider

BSE listing

Share price

₹11.44-0.56 (-4.67%)

as of 18 Sep 2026

52W high: ₹25.27
52W low: ₹10.15
Off 52W high: -54.73%
1M return: -2.05%
3M return: -9.99%
6M return: -26.90%
1Y return: -41.33%
20D avg volume: 13,759
50 DMA: ₹11.95
200 DMA: ₹16.13

Key ratios Consolidated

Market cap: ₹26.03 Cr
Current price: ₹11.44
52W high / low: ₹25.27 / ₹10.15
Face value: ₹10.00
P/E: -3.19
P/B: —
EPS (TTM): ₹-3.59
Book value / share: —
ROE: —
ROCE: -73.40%
Operating margin: —
Net margin: —
Debt / equity: 0.14
Net debt: ₹0.03 Cr
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 0.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q4 FY25
Income statement
	0.00	0.02	0.00	0.00	—
	0.00	0.03	0.00	0.00	—
	0.31	0.17	3.36	4.93	—
	0.00	0.00	0.00	0.00	—
	0.00	0.02	0.00	0.00	—
	0.10	0.08	0.05	0.10	—
	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	—
	0.22	0.07	3.30	4.83	—
	-0.31	-0.12	-3.36	-4.93	—
	0.00	0.00	0.00	0.00	—
	-0.31	-0.12	-3.36	-4.93	—
	0.00	0.00	0.00	0.00	—
	-0.19	-0.48	-2.94	-4.55	—
	-0.08	-0.06	-1.29	-2.00	—
Key metrics
	-0.31	-0.12	-3.36	-4.93	—
	—	-600.00%	—	—	—
	—	-2,400.00%	—	—	—
	—	-1.00%	—	-31.70%	—

Metric	TTM	FY26	FY25
Income statement
	0.02	0.02	—
	0.03	0.03	—
	8.77	8.74	—
	0.00	0.00	—
	0.02	0.02	—
	0.33	0.39	—
	0.00	0.00	—
	0.00	0.00	—
	8.42	8.33	—
	-8.72	-8.69	—
	0.00	0.00	—
	-8.72	-8.69	—
	0.00	0.00	—
	-8.16	-8.16	—
	-3.43	-3.99	—
Key metrics
	-8.72	-8.69	—
	-43,600.00%	-43,450.00%	—
	-40,800.00%	-40,800.00%	—
	—	-73.40%	—
	—	-5.02	—
	—	0.62	—
	—	0.14	—
	—	0.03	—
	—	0.0	—
Balance sheet
	—	14.38	—
	—	2.54	—
	—	1.63	—
	—	0.02	—
	—	0.00	—
	—	0.90	—
	—	0.00	—
	—	0.02	—
	—	2.54	—
	—	1.66	—
	—	1.66	—
	—	0.00	—
	—	11.75	—
Cash flow
	—	-5.02	—
	—	3.26	—
	—	3.39	—
	—	0.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.00	0.02	0.00	0.00	0.00	0.00	—
	0.00	0.03	0.00	0.00	0.00	0.00	—
	0.31	0.17	3.36	4.93	0.28	0.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.02	0.00	0.00	0.00	0.00	—
	0.10	0.08	0.05	0.10	0.16	0.05	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.22	0.07	3.30	4.83	0.12	0.04	—
	-0.31	-0.12	-3.36	-4.93	-0.28	-0.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.31	-0.12	-3.36	-4.93	-0.28	-0.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.31	-0.12	-3.36	-4.93	-0.28	-0.09	—
	-0.14	-0.06	-1.48	-2.17	-0.19	-0.06	—
Key metrics
	-0.31	-0.12	-3.36	-4.93	-0.28	-0.09	—
	—	-600.00%	—	—	—	—	—
	—	-600.00%	—	—	—	—	—
	—	-1.00%	—	-33.00%	—	-0.70%	—
	-10.70%	-33.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.02	0.02	0.00	—
	0.03	0.03	0.00	—
	8.77	8.74	0.26	—
	0.00	0.00	0.00	—
	0.02	0.02	0.00	—
	0.33	0.39	0.13	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	8.42	8.33	0.13	—
	-8.72	-8.69	-0.26	—
	0.00	0.00	0.00	—
	-8.72	-8.69	-0.26	—
	0.00	0.00	0.00	—
	-8.72	-8.69	-0.26	—
	-3.85	-4.25	-0.18	—
Key metrics
	-8.72	-8.69	-0.26	—
	-43,600.00%	-43,450.00%	—	—
	-43,600.00%	-43,450.00%	—	—
	—	-76.00%	-2.10%	—
	—	-3,242.30%	—	—
	—	-5.02	-0.23	—
	—	0.58	0.88	—
	—	0.15	0.20	—
	—	0.03	2.43	—
	—	0.0	—	—
Balance sheet
	—	13.97	15.68	—
	—	2.54	5.54	—
	—	1.63	0.00	—
	—	0.02	2.09	—
	—	0.00	0.00	—
	—	0.90	3.45	—
	—	0.00	0.01	—
	—	0.02	0.03	—
	—	2.54	3.48	—
	—	1.66	2.43	—
	—	1.66	2.43	—
	—	0.00	0.00	—
	—	11.34	12.08	—
Cash flow
	—	-5.02	-0.23	—
	—	3.26	0.00	—
	—	3.39	0.22	—
	—	0.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 25.44%

Holder	Type	Holding	Previous	Change
Krishnam Raju Kalidindi	Promoter	11.21%	—	—
Vase K B Christ	Public	7.73%	—	—
Chopperla N P Ravikanth	Public	7.10%	—	—
Ved Krishna Uppuluri	Public	5.16%	—	—
K. Nirusha	Promoter	4.52%	—	—
Sarvothama Reddy Morramreddygari	Public	3.34%	—	—
Mohammed Aejaz Habeeb	Promoter	3.26%	—	—
Siddarth Ravishankar Sarnaik	Public	3.06%	—	—
M Neela Reddy	Public	3.04%	—	—
Morramreddy Prabha Sameera	Public	2.92%	—	—
Syed Ameer Basha Paspala	Promoter	2.67%	—	—
Mallikarjun Rao Basaboini	Public	2.20%	—	—
Malathi Basaboina	Public	2.20%	—	—
Sarada Vijaya Kumari	Promoter	2.05%	—	—
Akkamahdevi Ravishankar Sarnaik	Public	1.87%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Announcement under Regulation 30 (LODR) - Newspaper Publication14 Aug 2026 · Company Update / General
Statement of Deviation or Variation for the quarter ended 30.06.202613 Aug 2026 · Company Update / General
Outcoem of Board Meeting held on 13.08.202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
un-audited Financial Results for the quarter ended 30.06.202613 Aug 2026 · Result / Financial Results
Scrutinizer''s Report for the 30th AGM held on 10.08.202610 Aug 2026 · AGM/EGM / AGM
Outcome of 30th Annual General Meeting held on 10.08.202610 Aug 2026 · AGM/EGM / AGM
Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve un-audited Financial Results ....5 Aug 2026 · Board Meeting / Board Meeting
Intimation of Newspaper Publication of 30th Annual General Meeting for the F.Y 2026-2720 Jul 2026 · Company Update / Newspaper Publication
Intimation of newspaper Publication of 30th Annual General Meeting for the F.Y 2026-2719 Jul 2026 · Company Update / Newspaper Publication
Newspaper advertisement regarding 30th Annual General Meeting.18 Jul 2026 · Company Update / Newspaper Publication
Annual Report for FY 2025-26 of the Company18 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice of AGM for the FY 2025-26 scheduled to be held on 10.08.202618 Jul 2026 · AGM/EGM / AGM
Newspaper Advertisement regarding 30th Annual General Meeting17 Jul 2026 · Company Update / Newspaper Publication
Update on the Outcome of Board Meeting held on 04.07.20268 Jul 2026 · Company Update / General
Update on the Outcome of Board Meeting held on 04.07.20267 Jul 2026 · Company Update / General
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 20187 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Appointment of Mr. Ravi Kanth Pattabhi Chopperla as an Additional Director in the Category of Professional and Non-Executive4 Jul 2026 · Company Update / Change in Management
Outcome of Board Meeting held on 04.07.20264 Jul 2026 · Corp. Action / Capital Reduction
Outcome of Board Meeting held on 04.07.20264 Jul 2026 · Board Meeting / Outcome of Board Meeting
Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 ,inter alia, to consider and approve 1. To consider and draft scheme ....29 Jun 2026 · Board Meeting / Board Meeting
Closure of Trading window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication of Audited Financial Resullts for the quarter and year ended 31.03.202630 May 2026 · Company Update / Newspaper Publication
Annual Secretarial Compliance Report for the year ended 31st March, 202630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Statement of deviation or variation for Q4 2025-2629 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Statement of Deviation or Variation - Q4 2025-2629 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Appointment of Internal Auditor for the F.Y 2026-2729 May 2026 · Company Update / General
outcome of board meeting held on 29.05.202629 May 2026 · Board Meeting / Outcome of Board Meeting
Audited Financial results (Standalone and Consolidated) for the quarter and year ended 31.03.202629 May 2026 · Result / Financial Results
Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited Financial Statement ....22 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....24 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....23 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Clarification w.r.t email received from BSE on 17.04.2026 regarding price movement is Submitted18 Apr 2026 · Company Update / General
The Exchange has sought clarification from Samsrita Labs Ltd on April 17, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....17 Apr 2026 · Company Update / Clarification
Certificate under Regulation 74(5) of SEBI (DP) Regulaitons, 20187 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading window28 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Strategic Expansion into the Pet Animal Healthcare and wellness segment11 Mar 2026 · Company Update / General
Newspaper Publication for un-audited financial results (standalone & Consolidated) for the quarter and nine months ended 31st December, 20257 Feb 2026 · Company Update / Newspaper Publication
Statement of deviation or variation for the quarter ended 31.12.20256 Feb 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
un-audited Financials Results for the quarter and nine months ended 31.12.20256 Feb 2026 · Result / Financial Results
un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025.6 Feb 2026 · Board Meeting / Outcome of Board Meeting

Board meetings

13 Aug 2026 Board Meeting - Financial Results